ATE444968T1 - Neuroprotektive verbindungen und deren verwendungen - Google Patents

Neuroprotektive verbindungen und deren verwendungen

Info

Publication number
ATE444968T1
ATE444968T1 AT07724832T AT07724832T ATE444968T1 AT E444968 T1 ATE444968 T1 AT E444968T1 AT 07724832 T AT07724832 T AT 07724832T AT 07724832 T AT07724832 T AT 07724832T AT E444968 T1 ATE444968 T1 AT E444968T1
Authority
AT
Austria
Prior art keywords
neuroprotective compounds
neuroprotective
compounds
dlhw
integer
Prior art date
Application number
AT07724832T
Other languages
English (en)
Inventor
Monika Hitzl
Herbert Moessler
Heinz Schnait
Original Assignee
Ebewe Neuro Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ebewe Neuro Pharma Gmbh filed Critical Ebewe Neuro Pharma Gmbh
Application granted granted Critical
Publication of ATE444968T1 publication Critical patent/ATE444968T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT07724832T 2006-05-03 2007-05-03 Neuroprotektive verbindungen und deren verwendungen ATE444968T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06450065A EP1857463A1 (de) 2006-05-03 2006-05-03 Neuroprotektive Wirkungen von Peptide
PCT/EP2007/003906 WO2007128493A1 (en) 2006-05-03 2007-05-03 Neuroprotective compounds and uses thereof

Publications (1)

Publication Number Publication Date
ATE444968T1 true ATE444968T1 (de) 2009-10-15

Family

ID=37084626

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07724832T ATE444968T1 (de) 2006-05-03 2007-05-03 Neuroprotektive verbindungen und deren verwendungen

Country Status (8)

Country Link
US (1) US8034778B2 (de)
EP (2) EP1857463A1 (de)
CN (1) CN101426807B (de)
AT (1) ATE444968T1 (de)
DE (1) DE602007002716D1 (de)
EA (1) EA016040B1 (de)
UA (1) UA94604C2 (de)
WO (1) WO2007128493A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6133772B2 (ja) 2010-06-15 2017-05-24 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 痛み治療用の医薬配合物
GB2539161A (en) * 2014-11-26 2016-12-14 Neuro-Bio Ltd Neurodegenerative disorders
JP6670922B2 (ja) 2015-07-08 2020-03-25 チャイナ ナショナル リサーチ インスティテュート オブ フード アンド ファーメンテーション インダストリーズ Ａｍｐａ受容体を阻害する活性ペプチド、ならびにその調製方法およびその使用
PL4114843T3 (pl) 2020-07-13 2024-02-12 Ever Neuro Pharma Gmbh Sposób wytwarzania hydrolizatu białek mózgu ssaka

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0452299B1 (de) 1990-04-12 1997-06-18 EBEWE Arzneimittel Gesellschaft mbH Verwendung einer Mischung von Peptiden and Aminosäuren für die Prophylaxis oder Behandlung von Dementia
AUPN568095A0 (en) * 1995-09-27 1995-10-26 Austin Research Institute, The Anti-Galalpha(1,3)Gal antibody binding peptides
RU2155063C1 (ru) * 1999-10-20 2000-08-27 Санкт-Петербургская общественная организация "Институт биорегуляции и геронтологии" Тетрапептид, стимулирующий функциональную активность нейронов, фармакологическое средство на его основе и способ его применения
NZ522924A (en) * 2000-05-26 2004-12-24 Ortho Mcneil Pharm Inc Neuroprotective peptides
GB0014870D0 (en) * 2000-06-16 2000-08-09 King S College London Peptides
WO2004011650A2 (en) * 2002-07-24 2004-02-05 Intercell Ag Antigens encoded by alternative reading frame from pathogenic viruses

Also Published As

Publication number Publication date
EP2032596B1 (de) 2009-10-07
CN101426807A (zh) 2009-05-06
UA94604C2 (en) 2011-05-25
DE602007002716D1 (de) 2009-11-19
US20090105159A1 (en) 2009-04-23
EA200802273A1 (ru) 2009-04-28
WO2007128493A1 (en) 2007-11-15
EP2032596A1 (de) 2009-03-11
HK1128703A1 (en) 2009-11-06
US8034778B2 (en) 2011-10-11
EA016040B1 (ru) 2012-01-30
EP1857463A1 (de) 2007-11-21
CN101426807B (zh) 2012-08-29

Similar Documents

Publication Publication Date Title
LTC1856135I2 (lt) 2,4-pirimidindiamino junginių provaistai ir jų panaudojimas
IL185275A0 (en) N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same
UY29856A1 (es) Forma cristalina 8d del clorhidrato de la ivabradina, su procedimiento de preparación, y las composiciones farmaceuticas que la contienen
CY1110398T1 (el) Ενωσεις για την αγωγη της δυσλιπιδαιμιας
ATE547415T1 (de) Inhibitoren der wechselwirkung zwischen mdm2 und p53
EP2248869A3 (de) Verbindungen für organische elektronische Vorrichtungen
CY1112780T1 (el) Νεα σουλφονυλοπυρρολια ως αναστολεις της ηdac
ATE523544T1 (de) Alkylierte aminopropylierte ethyendiamine und verwendungen davon
ATE498669T1 (de) 2,6-naphthylreste enthaltende verbindungen
ATE523543T1 (de) Alkylierte aminoproyliertes methylen-di- (cyclohexylamin) und verwendungen davon
TW200722424A (en) Substituted piperidines
ATE444968T1 (de) Neuroprotektive verbindungen und deren verwendungen
DE602006019732D1 (de) Indolylmaleimidderivate
CY1111081T1 (el) Νεα μεθοδος συνθεσης του (7-μεθοξυ-1-ναφθυλ) ακετονιτριλιου και εφαρμογη στη συνθεση της αγκομελατινης
TW200700358A (en) Organic compounds
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
TW200740781A (en) Novel compounds
WO2007062526A8 (en) Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation
ATE371662T1 (de) Siliziumverbindungen und deren verwendung
ATE422531T1 (de) Organische verbindungen
DE602006014530D1 (de) Pharmazeutisch aktive diazepane
SG165381A1 (en) Novel benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use in particular as c-met inhibitors
EA200801139A1 (ru) Композиция для аэрозольной ингаляции
TW200619250A (en) Resin composition and resin sheet for optical use, and optical semiconductor device
SE0402734D0 (sv) Antimiicrobial compounds

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2032596

Country of ref document: EP